.
ITRM financial statements
* Numbers in thousands
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
Capitalization * |
96 693 | 36 440 | 22 017 | 5 856 |
EV * |
66 240 | 45 064 | 49 848 | 49 848 |
Stock price $ |
6.73 | 2.51 | 1.41 | 0.375 |
Number of shares * |
14 367 | 14 518 | 15 615 | 15 615 |
EPS |
-5,36 | -7,10 | -3,33 | -3,33 |
Revenue * |
869 | 37 | 0 | 0 |
Net income * |
-77 056 | -103 130 | -52 006 | -52 006 |
Operating profit * |
-76 559 | -102 021 | -32 126 | -32 126 |
Total liabilities * |
26 249 | 51 989 | 83 351 | 83 351 |
Net debt * |
-30 453 | 8 624 | 27 831 | 27 831 |
Total assets * |
97 871 | 25 751 | 32 792 | 32 792 |
Equity * |
71 622 | -26 238 | -50 559 | -50 559 |
Cash and investments * |
85 510 | 5 940 | 14 508 | 14 508 |
Over the past 10 years, the maximum capitalization of Iterum Therapeutics plc is 96 693, the minimum is 22 017. Maximum net income 0, Minimum net income -103 130. The maximum price of ITRM shares is 6.73, the minimum price is 1.41.
.
ITRM valuation
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
P/E |
-1,25 | -0,35 | -0,42 | -0,11 |
P/B |
1,35 | -1,39 | -0,44 | -0,12 |
P/S |
111,27 | 984,87 | 0,00 | 0,00 |
E/P |
-80% | -283% | -236% | -888% |
P/FCF |
-1,27 | -0,46 | -0,40 | -0,11 |
.
ITRM profitability
Year |
2018 | 2019 | 2020 | TTM |
|---|---|---|---|---|
ROE |
-108% | 393% | 103% | |
ROA |
-79% | -400% | -159% | |
ROIC |
-89% | 908% | 361% |